Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.94 |
High Similarity |
NPD4380 |
Phase 2 |
0.9342 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9177 |
High Similarity |
NPD6166 |
Phase 2 |
0.9177 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.9177 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.915 |
High Similarity |
NPD1934 |
Approved |
0.9038 |
High Similarity |
NPD7075 |
Discontinued |
0.9038 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.9032 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8968 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8961 |
High Similarity |
NPD7411 |
Suspended |
0.894 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.894 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8919 |
High Similarity |
NPD1549 |
Phase 2 |
0.8868 |
High Similarity |
NPD6959 |
Discontinued |
0.8854 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8851 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8851 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8782 |
High Similarity |
NPD6801 |
Discontinued |
0.8773 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8727 |
High Similarity |
NPD6559 |
Discontinued |
0.8726 |
High Similarity |
NPD2801 |
Approved |
0.8726 |
High Similarity |
NPD7819 |
Suspended |
0.872 |
High Similarity |
NPD7074 |
Phase 3 |
0.8688 |
High Similarity |
NPD5494 |
Approved |
0.8659 |
High Similarity |
NPD5844 |
Phase 1 |
0.8659 |
High Similarity |
NPD7054 |
Approved |
0.8658 |
High Similarity |
NPD2796 |
Approved |
0.8627 |
High Similarity |
NPD1511 |
Approved |
0.8616 |
High Similarity |
NPD3882 |
Suspended |
0.8606 |
High Similarity |
NPD7472 |
Approved |
0.8598 |
High Similarity |
NPD3818 |
Discontinued |
0.8591 |
High Similarity |
NPD1510 |
Phase 2 |
0.8589 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8554 |
High Similarity |
NPD6797 |
Phase 2 |
0.8516 |
High Similarity |
NPD1512 |
Approved |
0.8506 |
High Similarity |
NPD6799 |
Approved |
0.8503 |
High Similarity |
NPD7251 |
Discontinued |
0.85 |
High Similarity |
NPD7768 |
Phase 2 |
0.8452 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8446 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8443 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8438 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8438 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8366 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8354 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8343 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8313 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8302 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8221 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8217 |
Intermediate Similarity |
NPD5401 |
Approved |
0.817 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8081 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8081 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8077 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8077 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8068 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8067 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7989 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7987 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7987 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7961 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7961 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7949 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7927 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7925 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7901 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7888 |
Intermediate Similarity |
NPD920 |
Approved |
0.7875 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7871 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7844 |
Intermediate Similarity |
NPD919 |
Approved |
0.7843 |
Intermediate Similarity |
NPD943 |
Approved |
0.7829 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7785 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7771 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7765 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD6780 |
Approved |
0.776 |
Intermediate Similarity |
NPD6776 |
Approved |
0.776 |
Intermediate Similarity |
NPD6779 |
Approved |
0.776 |
Intermediate Similarity |
NPD6778 |
Approved |
0.776 |
Intermediate Similarity |
NPD6782 |
Approved |
0.776 |
Intermediate Similarity |
NPD6777 |
Approved |
0.776 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7756 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7753 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7742 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7736 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7713 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7711 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7707 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7707 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7703 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7701 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7697 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7647 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7647 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.764 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7634 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7597 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7594 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7594 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7578 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7564 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7545 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.754 |
Intermediate Similarity |
NPD7697 |
Approved |
0.754 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.754 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7539 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7539 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1203 |
Approved |
0.75 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD5710 |
Approved |
0.75 |
Intermediate Similarity |
NPD5711 |
Approved |
0.75 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7487 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7486 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7486 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7486 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7484 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7484 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7474 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7469 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7468 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7467 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7457 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7452 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7452 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.744 |
Intermediate Similarity |
NPD37 |
Approved |
0.7436 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7429 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7427 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7412 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD4966 |
Approved |
0.741 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7401 |
Intermediate Similarity |
NPD3823 |
Discontinued |
0.7396 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7396 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7394 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7366 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7366 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7358 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7351 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7351 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7342 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7338 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7333 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD4661 |
Approved |
0.7333 |
Intermediate Similarity |
NPD4662 |
Approved |
0.733 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7312 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7301 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7294 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7294 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7292 |
Intermediate Similarity |
NPD7585 |
Approved |
0.729 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7268 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7263 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7261 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7261
|
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |